2019
DOI: 10.1016/j.jacc.2019.02.061
|View full text |Cite
|
Sign up to set email alerts
|

Atrial Functional Mitral Regurgitation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
203
0
5

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 284 publications
(214 citation statements)
references
References 54 publications
6
203
0
5
Order By: Relevance
“…7 One of the components of SMR is dilation of the mitral valve annulus (MA) and increased left atrial volume (LAV). 8 The Carillon Mitral Contour System ® (CMCS; Cardiac Dimensions, Inc., Kirkland, WA, USA) is the only device having CE approval to treat mitral regurgitation by addressing MA dilation through indirect annuloplasty, utilizing the proximity of the coronary sinus (CS) to the MA. Several studies have shown the safety and efficacy of the device with reduction in mitral regurgitation grade and improvement in exercise capacity, quality of life, [9][10][11] and left ventricular (LV) reverse remodelling.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…7 One of the components of SMR is dilation of the mitral valve annulus (MA) and increased left atrial volume (LAV). 8 The Carillon Mitral Contour System ® (CMCS; Cardiac Dimensions, Inc., Kirkland, WA, USA) is the only device having CE approval to treat mitral regurgitation by addressing MA dilation through indirect annuloplasty, utilizing the proximity of the coronary sinus (CS) to the MA. Several studies have shown the safety and efficacy of the device with reduction in mitral regurgitation grade and improvement in exercise capacity, quality of life, [9][10][11] and left ventricular (LV) reverse remodelling.…”
Section: Introductionmentioning
confidence: 99%
“…One of the components of SMR is dilation of the mitral valve annulus (MA) and increased left atrial volume (LAV) 8 . The Carillon Mitral Contour System ® (CMCS; Cardiac Dimensions, Inc., Kirkland, WA, USA) is the only device having CE approval to treat mitral regurgitation by addressing MA dilation through indirect annuloplasty, utilizing the proximity of the coronary sinus (CS) to the MA.…”
Section: Introductionmentioning
confidence: 99%
“…Besides ischemic and non-ischemic subgroups, SMR etiologies can be separated by LV-LA function. Among those is ASMR, as previously mentioned [54,65,66] . While our knowledge of anatomy and pathophysiology of ASMR is growing, specific predictors for all-cause mortality after TMVr are so far lacking [66] .…”
Section: Smr Only Collectivementioning
confidence: 99%
“…Left atrial dysfunction in SMR patients recently gained attention as this condition can lead to MR in absence of severe systolic LV dysfunction. This pathology called atrial secondary mitral regurgitation (ASMR) is caused by either atrial fibrillation or heart failure with preserved ejection fraction (HFpEF), as both increase LA pressure and volume leading to annular flattening and alteration of left ventricular atrioventricular hemodynamics [54] . As HFpEF patients with SMR were excluded from large controlled randomized trials (COAPT or MITRA-FR) [12,13] , but undergo TMVr procedure in real-world clinical practice, impact of ASMR on survival and procedural success warants further investigation.…”
Section: Smr Only Collectivementioning
confidence: 99%
“…Th is raises the question whether the MV geometrical conformation is more dependent on the LA morphology than on the LV volumes and function. Th e concept of atrial functional mitral regurgitation is currently regarded as distinct from the secondary mitral regurgitation which appears as a consequence of LV deformation 8 . Future studies are needed to establish the intimate relationships between MV geometrical distortion, LV and LA morphology and function.…”
Section: Relationship Between MV Geometry and Lv And La Parametersmentioning
confidence: 99%